Dendritic Cell-based Immunization for Cancer Therapy

  • Michael A. Morse
  • H. Kim Lyerly
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 465)


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Alijagic, S., Moller, P., Artuc, M., Jurgovsky, K., Czarnetzki P.M., and Schadendorf, D., 1995, Dendritic cells generated from peripheral blood transfected with human tyrosinase induce specific T cell activation, Eur. J. Immunol. 25:3100–3107.PubMedCrossRefGoogle Scholar
  2. Alters, S.E., Gadea, J.R., Sorich, M., O’Donoghue, G., Talib, S., and Philip, R., 1998, Dendritic cells pulsed with CEA peptide induce CEA-specific CTL with restricted TCR repertoire, J. Immunother. 21:17–26.PubMedCrossRefGoogle Scholar
  3. Anichini, A., Mortarini, R., Maccalli, C., Squarcina, P., Fleischhauer, K., Mascheroni, L., and Parmiani, G., 1996, Cytotoxic T cells directed to tumor antigens not expressed on normal melanocytes dominate HLA-A2.1-restricted immune repertoire to melanoma, J. Immunol. 156:208–217.PubMedGoogle Scholar
  4. Asley, D.M., Faiola, B., Nair, S. Hale, L.P., Bigner, D., and Gilboa, E., 1997, Bone marrow-generated dendritic cells pulsed with tumor extracts or tumor RNA induce antitumor immunity against central nervous system tumors, J. Exp. Med. 7:1177–1182.CrossRefGoogle Scholar
  5. Austyn, J., 1996, New insights into the mobilization and phagocytic activity of dendritic cells, J. Exp. Med. 183:1287–1292.PubMedCrossRefGoogle Scholar
  6. Azizi, E., Bunana, C., Goldberg, L., and Kripke, M.L., 1987, Perturbations of epidermal Langerhans cells in basal cell carcinoma, Am. J. Dermatopath. 9:465–473.PubMedGoogle Scholar
  7. Bannerji, R., Arroyo, C.D., Cordon-Cardo, C., and Gilboa, E., 1994, The role of IL-2 secreted from genetically modified tumor cells in the establishment of antitumor immunity, J. Immunol. 152:2324–2332.PubMedGoogle Scholar
  8. Barnd, D.L., Lan, M.S., Metzgar, R.S., and Finn, O.J., 1989, Specific MHC-unrestricted recognition of tumor associated mucins by human cytotoxic cells, Proc. Natl. Acad. Sci. USA 86:7159–63.PubMedCrossRefGoogle Scholar
  9. Becker, Y, 1993, Dendritic cell activity against primary tumors: an overview, In Vivo 7:187–191.PubMedGoogle Scholar
  10. Becker, Y., 1992, Anticancer role of dendritic cells (DC) in human and experimental cancers-areview, Anti-cancer Res. 12:511–520.Google Scholar
  11. Bender, A., Sapp, M., Schuler, G., Steinman, R.M., and Bhardwaj, N., 1996, Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood, J. Immunol. Methods 196:121–135.PubMedCrossRefGoogle Scholar
  12. Boczkowski, D., Nair, S., Snyder, D., and Gilboa, E., 1996, Dendritic cells pulsed with RNA are potent antigen presenting cells in vitro and in vivo, J. Exp. Med. 184:465–472.PubMedCrossRefGoogle Scholar
  13. Bos, J.L., 1989, ras Oncogenes in human cancer: a review, Cancer Res. 49:4682.PubMedGoogle Scholar
  14. Bulbul, M.A., Huben, R.P., and Murpy, G.P., 1989, Interferon-β treatment of metastatic prostate cancer, J. Surg. Oncol. 33:231–233.CrossRefGoogle Scholar
  15. Caux, C., Vandervliet, B., Massacrier, C., Dezutter-Dambuyant, C., de Saint-Vis, B., Jacquet, C., Yoneda, K., Imamura, S., Schmitt, D., and Banchereau, J., 1996, CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNFα, J. Exp. Med. 184:695–706.PubMedCrossRefGoogle Scholar
  16. Cavanagh, L.L., Saal, R.J., Grimmett, K.L., and Thomas, R., 1998, Proliferation in monocyte-derived den-dritic cell cultures is caused by progenitor cells capable of myeloid differentiation, Blood 92:1598–1607.PubMedGoogle Scholar
  17. Cella, M., Scheidegger, D., Palmer-Lehmann, K., Lane, P., Lanzavecchia, A., and Alber, G., 1996, Ligation of CD40 on dendritic cells triggers production of high level of interleukin-12 and enhances T cell stimulator capacity: T-T help via APC activation, J. Exp. Med. 184:747–752.PubMedCrossRefGoogle Scholar
  18. Celluzzi, C.M., Mayordomo, J.I., Storkus, W.J., Lotze, M.T., and Falo, J.L.D., 1996, Peptide-pulsed dendritic cells induce antigen-specific, CTL-mediated protective tumor immunity, J. Exp. Med. 183:283–287.PubMedCrossRefGoogle Scholar
  19. Coulie, P.G., Somville, M., Lehmann, F., Hainaut, P., Brasseur, F., Devos, R., and Boon, T., 1992, Precursor frequency analysis of human cytolytic T lymphocytes directed against autologous melanoma cells, Int. J. Cancer 50:289–297.PubMedCrossRefGoogle Scholar
  20. Disis, M.L, and Cheever, M.A., 1997, HER-2/neu protein: A target for antigen-specific immunotherapy of human cancer, Adv. Cancer Res. 71:343–371.PubMedCrossRefGoogle Scholar
  21. Darrow, T., Slingluff, C., and Seigler, H, 1989, The role of HLA class I antigens in recognition of melanoma cells by tumor-specific cytotoxic T lymphocytes. Evidence for shared tumor antigens, J. Immunol. 42:3329–3335.Google Scholar
  22. Disis, M.L., Calenoff, E., McLaughlin, G., Murphy, A.E., Chen, W., Groner, B., Jeschke, M., Lydon, N., McGlynn, E., Livingston, R.B., and Cheever, M., 1994, Existent T cell and antibody immunity to HER-2/neu protein in patients with breast cancer, Cancer Res. 54:1620.Google Scholar
  23. Fisk, B., Blevins, T.L., Wharton, J.T., and Loannides, C.G., 1995, Identification of an immunodominant peptide of HER-2/neu proto-oncogene recognized by ovarian tumorspecific cytotoxic T lymphocyte lines, J. Exp. Med. 181:2109–2117.PubMedCrossRefGoogle Scholar
  24. Flamand, V., Sornasse, T., Thielemans, K., Demanet, C., Bakkus, M., Bazin, H., Tielemans, F., Leo, O., Urbain, J., and Moser, M., 1994, Murine dendritic cells pulsed in vitro with tumor antigen induce tumor resistance in vivo, Eur. J. Immunol. 24:605–610.PubMedCrossRefGoogle Scholar
  25. Gabrilovich, D.I., Ciernik, I.F., and Carbone, D.P., 1996, Dendritic cells in antitumor immune responses. I. Defective antigen presentation in tumor-bearing hosts, Cell. Immunol. 170:101–110.PubMedCrossRefGoogle Scholar
  26. Gabrilovich, D.I., Nadaf, S., Corak, J., Berzofsky, J.A., and Carbone, D.P., 1996, Dendritic cells in antitumor immune responses. II Dendritic cells grown from bone marrow precursors, but not mature DC from tumor bearing mice, are effective antigen carriers in the therapy of established tumors, Cell. Immunol. 170:111–119.PubMedCrossRefGoogle Scholar
  27. Galy, A., Travis, M., Cen, D., and Chen, B., 1995, Human T, B, natural killer, and dendritic cells arise from a common bone marrow progenitor cell subset, Immunity 3:459–73.PubMedCrossRefGoogle Scholar
  28. Gong, J, Chen, D., Kashiwaba, M., and Kufe, D., 1997, Induction of antitumor activity by immunization with fusions of dendritic and carcinoma cells, Nature Med. 3:558–61.PubMedCrossRefGoogle Scholar
  29. Grouard, G., Durand, I., Filgueira, L., Banchereau, J., and Liu, Y.J., 1996, Dendritic cells capable of stimulating T cells in germinal centers, Nature 384:364–367.PubMedCrossRefGoogle Scholar
  30. Grouard, G., Rissoan, M.C., Filgueira, L., Durand, I. Banchereau, J., and Liu, Y.J., 1997, The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand, J. Exp. Med. 185:1101–1111.PubMedCrossRefGoogle Scholar
  31. Halbert, C., Demers, G.W., and Galloway, D.A., 1991, The E7 gene of human papillomavirus type 16 is sufficient for immortalization of human epithelial cells, J. Viral. 65:473–478.Google Scholar
  32. Hinkel, A., Gitlitz, B., Mulders, P., Moldawer, N., Tso, C., Kaboo, R., Belldegrun, A., and Figlin, R., 1998, Dendritic cell therapy for metastatic renal cell carcinoma-A translational phase I clinical trial, Proc. Am. Soc. Clin. Oncol. 17:432a.Google Scholar
  33. Hock, B.D., Starling, G.C., Daniel, P.B., and Hart, D.N.J., 1994, CMRF-44, a novel monoclonal antibody to an activation antigen expressed by the allostimulatory cells within peripheral blood, including dendritic cells, Immunol. 83:573–581.Google Scholar
  34. Hsu, F.J., Benike, C., Fagnoni, F., Liles, T.M., Czerwinski, D., Taidi, B., Engleman, E.G., and Levy, R., 1996, Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nature Med. 2:52–58.PubMedCrossRefGoogle Scholar
  35. Huang, A.Y.C., Golumbek, P., Ahmadzedah, M., Jaffee, E., Pardoll, D., and Levitsky, H., 1994, Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens, Science 264:961–965.PubMedCrossRefGoogle Scholar
  36. Inaba, K., Young, J.W., and Steinman, R.M., 1987, Direct activation of CD8+ cytotoxic T lymphocytes by dendritic cells, J Exp Med. 166:182–194.PubMedCrossRefGoogle Scholar
  37. Kawakami, Y., Eliyahu, S., Delgado, C.H., Robbins, P.F., Rivoltini, L., Topalian, S.L., Miki, T., and Rosenberg, S.A., 1994, Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor, Proc. Natl. Acad Sci. USA 91:3515–3519.PubMedCrossRefGoogle Scholar
  38. Knight, S.C., Farrant, J., Bryant, A., Edwards, A.J., Burman, S., Lever, A., Clarke, J., and Webster, A.D., 1986, Non-adherent, low-density cells from human peripheral blood contain dendritic cells and monocytes, both with veiled morphology, Immunol. 57:595–603.Google Scholar
  39. Liu, Y.J., Grouard, G., De Boutteillier, O., and Banchereau, J., 1996, Follicular dendritic cells and germinal centers. Int. Rev. Cytol. 166:139–179.PubMedCrossRefGoogle Scholar
  40. Macatonia, S.E., Taylor, P.M., Knight, S.C., and Askonas, B.A., 1988, Primary stimulation by dendritic cells induces antiviral proliferative and cytotoxic T cell responses in vitro, J. Exp. Med. 169:1255–1264.CrossRefGoogle Scholar
  41. Maraskovsky, E., Brasel, K., Teepe, M., Roux, E.R., Lyman, S.D., Shortman, K., and McKenna, H.J., 1996, Dramatic increase in the number of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations identified, J. Exp. Med. 184:1953–1962.PubMedCrossRefGoogle Scholar
  42. Matzinger, P., 1994, Tolerance, danger, and the extended family, Ann. Rev. Immunol. 12:991–1045.Google Scholar
  43. Mayordomo, J.I., Zorina, T., Storkus, W.J., Zitvogel, L., Celluzzi, C., Falo, L.D., Melief, C.J., Ildstad, S.T., Kast, W.M., Deleo, A.B., and Lotze, M.T., 1995, Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity, Nature Med. 12:1297–1302.Google Scholar
  44. Mazzocchi, A., Belli, F., Mascheroni, L., Vegetti, C., Parmiani, G., and Anichini, A., 1994, Frequency of cyto-toxic T lymphocyte precursors (CTLp) interacting with autologous tumor via the T-cell receptor: limiting dilution analysis of specific CTLp in peripheral blood and tumor invaded lymph nodes of melanoma patients, Int. J. Cancer. 58:330–339.PubMedCrossRefGoogle Scholar
  45. McKinney, E.C., and Streilein, E.W., 1989, On the extraordinary capacity of allogeneic epidermal langerhans cells to prime cytotoxic T cells in vivo, J. Immunol 143:1560–1564.PubMedGoogle Scholar
  46. Mehta-Damani, A., Markowicz, S., and Engleman, E.G., 1994, Generation of antigen-specific CD8+ CTLs from naive precursors, J. Immunol. 153:996–1003.PubMedGoogle Scholar
  47. Morse, M.A., Zhou, L.-J., Tedder, T.F., Lyerly, H.K., and Smith, C., 1997, Generation of dendritic cells in vitro from peripheral blood mononuclear cells with GM-CSF, IL-4, and TNF-a for use in cancer immunotherapy, Ann. Surg. 226:6–16.PubMedCrossRefGoogle Scholar
  48. Morse, M.A., Lyerly, H.K., Gilboa, E., Thomas, E., and Nair, S.K, 1998, The role of CD40-ligand in induction of dendritic cell maturation, Cancer Res. (In Press).Google Scholar
  49. Mortarini, R., Anichini, A., Di Nicola, M., Siena, S., Bregni, M., Belli, F., Molla, A., Gianni, A.M., and Parmiani, G., 1997, Autologous dendritic cells derived from CD34+ progenitors and from monocytes are not functionally equivalent antigen-presenting cells in the induction of Melan-A/Mart-127–35-specific CTLs from peripheral blood lymphocytes of melanoma patients with low frequency of CTL precursors, Cancer Res. 57:5534–5541.PubMedGoogle Scholar
  50. Mukherji, B., Chakraborty, N.G., Yamasaki, S., Okino, T., Yamase, H., Sporn, J.R., Kurtzman, S.K., Ergin, M.T., Ozols, J., and Meehan, J., 1995, Induction of antigen-specific cytolytic T cells in situ in human melanoma by immunization with synthetic peptide-pulsed autologous antigen presenting cells, Proc. Natl. Acad. Sci. USA 92:8078–8082.PubMedCrossRefGoogle Scholar
  51. Murphy, G., Tjoa, B., Ragde, H., Kenny, G., and Boynton, A., 1996, Phase I clinical trial: T-cell therapy for prostate cancer using autologous dendritic cells pulsed with HLA-A0201-specific peptides from prostate-specific membrane antigen, The Prostate 29:371–380.PubMedCrossRefGoogle Scholar
  52. Nair, S., Zhou, F, Reddy, R., Huang, L., and Rouse, B.T., 1992, Soluble proteins delivered to dendritic cells via pH-sensitive liposomes induce primary cytotoxic T lymphocyte responses in vitro, J. Exp. Med. 175:609–612.PubMedCrossRefGoogle Scholar
  53. Nair, S., Babu, J.S., Dunham, R.G., Kanda, P., Burke, R.L., and Rouse, B.T., 1993, Induction of primary, antiviral cytotoxic, and proliferative responses with antigens administered via dendritic cells, J. Virol. 67:4062–4069.PubMedGoogle Scholar
  54. Nair, S.K., Bocczowski, D., Morse, M.A., Cumming, R.I., Lyerly, H.K., and Gilboa, E., 1998, Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA, Nature Biotech. 16:1–8.CrossRefGoogle Scholar
  55. Nair, S.K., Snyder, YD., Rouse, B.T., and Gilboa, E., 1997, Regression of tumors in mice vaccinated with professional antigen-presenting cells pulsed with tumor extracts, Int. J. Cancer 70:706–715.PubMedCrossRefGoogle Scholar
  56. Nestle, F.O., Alijagic, S., Gilliet, M., Sun, Y, Grabbe, S., Dummer, R., Burg, G., and Schadendorf, D., 1998, Vaccination of melanoma patients with peptide-or tumor lysate-pulsed dendritic cells, Nature Med. 4:328–332.PubMedCrossRefGoogle Scholar
  57. Ossevoort, M.A., Feltkamp, M.C.W., Van Veen, K.J.H., Melief, C.J., and Kast, W.M., 1995, Dendritic cells as carriers for a cytotoxic T-lymphocyte epitope-based peptide vaccine in protection against a human papillomavirus type 16-induced tumor, J. Immunother. 18:86–94.CrossRefGoogle Scholar
  58. Paglia, P., Chiodoni, C., Rodolfo, M., and Colombo, M.P., 1996, Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo, J. Exp. Med. 183:317–322.PubMedCrossRefGoogle Scholar
  59. Porgador, A., Snyder, D., and Gilboa, E., 1996, Induction of antitumor immunity using bone marrow-generated dendritic cells, J. Immunol. 156:2918–2926.PubMedGoogle Scholar
  60. Porgador, A., and Gilboa, E., 1995, Bone marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes, J. Exp. Med. 182:255–260.PubMedCrossRefGoogle Scholar
  61. Reichardt, V., Okada, C., Benike, C., Long, G., Engleman, E., Blume, K., and Levy, R., 1996, Idiotypic vaccination using dendritic cells for multiple myeloma patients after autologous peripheral blood stem cell transplantation, Blood 88:481 (Abstract).Google Scholar
  62. Reid, C.D.L., Stackpoole, A., Meager, A., and Tikerpae, J., 1992, Interactions of tumor necrosis factor with granulocyte-macrophage colony-stimulating factor and other cytokines in the regulation of dendritic cell growth in vitro from early bipotent CD34+ progenitors in human bone marrow, J. Immunol. 149:2681–2688.PubMedGoogle Scholar
  63. Reeves, M.E., Royal, R.E., Lam, J.S., Rosenberg, S.A., and Hwu, P., 1996, Retroviral transduction of human dendritic cells with a tumor-associated antigen gene, Cancer Res. 56:5672–5677.PubMedGoogle Scholar
  64. Robinson, M.R., Rigby, C.C., Pugh, C.B., and Dumonde, D.C., 1977, Adjuvant immunotherapy with BCG in carcinoma of the prostate, Br. J. Urol. 49:221–226.PubMedGoogle Scholar
  65. Romani, N., Gruner, S., Brang, D., Kampgen, E., Lenz, A., Trockenbacher, B., Konwalinka, G., Fritsch, P.O., Steinman, R.M., and Schuler, G., 1994, Proliferating dendritic cell progenitors in human blood, J. Exp. Med. 180:83–93.PubMedCrossRefGoogle Scholar
  66. Romani, N., Reider, D., Heuer, M., Ebner, S., Kampgen, E., Eibl, B., Niederwieser, D., and Schuler, G., 1996, Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability, J. Immunol. Methods (1996) 196:137–151.PubMedCrossRefGoogle Scholar
  67. Rosenberg, S.A., Lotze, M.T., Muul, L.M., Chang, A.E., Avis, F.P., Leitman, S., Linehan, W.M., Robertson, C.N., Lee, R.E., and Rubin, J.T., 1987, A progress report on the treatment of 157 patients with advanced cancer using lymphokine activated killer cells and interleukin-2 or high-dose interleukin-2 alone, N. Engl. J. Med. 316(15):889–897.PubMedCrossRefGoogle Scholar
  68. Rosenberg, S.A., Lotze, M.T., Yang, J.C., Aebersold, P.M., Linehan, W.M., Seipp, C.A., and White, D.E., 1989, Experience with the use of high-dose interleukin-2 in the treatment of 652 patients with cancer, Ann. Surg. 210:474–485.PubMedCrossRefGoogle Scholar
  69. Rouse, R.J.D., Nair, S.K., Lydy, S.L., Bowen, J.C., and Rouse, B.T., 1994, Induction in vitro of primary cytotoxic T-lymphocytes responses with DNA encoding herpes simplex virus proteins, J. Virol. 68:5685–5689.PubMedGoogle Scholar
  70. Santiago-Schwarz, F., Belilos, E., Diamond, B., and Carsons, S.E., 1992, TNF in combination with GM-CSF enhances the differentiation of neonatal cord blood stem cells into dendritic cells and macrophages, J. Leuk. Biol. 52:274–281.Google Scholar
  71. Saunders, D., Lucas, K., Ismaili, J., Wu, L., Maraskovsky, E., Dunn, A., and Shortman, K., 1996, Dendritic cell development in culture from thymic precursor cells in the absence of granulocyte/macrophage colony-stimulating factor, J. Exp. Med. 184:2185–2196.PubMedCrossRefGoogle Scholar
  72. Siena, S., Di Nicola, M., Bregni, M., Mortarini, R., Anichini, A., Lombardi, L., Ravagnani, F., Parmiani, G., and Gianni, A.M., 1995, Massive ex vivo generation of functional dendritic cells from mobilized CD34+ blood progenitors for anti-cancer therapy, Exp. Hematol. 23:1463–1471.PubMedGoogle Scholar
  73. Song, W., Kong, H.L., Carpenter, H., Torii, H., Granstein, R., Rafii, S., Moore, M.A.S., and Crystal, R.G., 1997, Dendritic cells genetically modified with an adenovirus vector encoding the cDNA for a model antigen induce protective and therapeutic antitumor immunity, J. Exp. Med. 186:1247–1256.PubMedCrossRefGoogle Scholar
  74. Specht, J.M., Wang, G., Do, M.T., Lam, J.S., Royal, R.E., Reeves, M.E., Rosenberg, S.A., and Hwu, P., 1997, Dendritic cells retrovirally transduced with a model antigen gene are therapeutically effective against established pulmonary metastases, J. Exp. Med., 186:1213–1221.PubMedCrossRefGoogle Scholar
  75. Steinman, R.M., and Swanson, J., 1995, The endocytic activity of dendritic cells, J. Exp. Med. 182:283–88.PubMedCrossRefGoogle Scholar
  76. Steinman, R.M., 1991, The dendritic cell system and its role in immunogenicity, Ann. Rev. Immunol. 9:271–296.CrossRefGoogle Scholar
  77. Strobl, H., Scheinecker, C., Riedl, E., Csmarits, B., Bello-Fernandez, C., Pickl, W.F., Majdic, O., and Knapp, W., 1998, Identification of CD68+lin-peripheral blood cells with dendritic precursor characteristics, J. Immunol. 161:740–748.PubMedGoogle Scholar
  78. Suss, G., and Shortman, K., 1996, A subclass of dendritic cells kills CD4 T cells via Fas/Fas-ligand-induced apoptosis, J. Exp. Med. 183:1789–1796.PubMedCrossRefGoogle Scholar
  79. Szabolcs, P., Moore, M.A., and Young, J.W, 1995, Expansion of immunostimulatory dendritic cells among the myeloid progeny of human CD34+ bone marrow precursors cultured with c-kit ligand, granulocyte-macrophage colony-stimulating factor, and TNF-α, J. Immunol. 154:5851–5861.PubMedGoogle Scholar
  80. Szabolcs, P., Avigan, D., Gezelter, S., Ciocon, D.H., Moore, M.A., Steinman, R.M., and Young, J.W., 1996, Dendritic cells and macrophages can mature independently from a human bone marrow-derived, postcolony forming unit intermediate, Blood 87:4520–4530.PubMedGoogle Scholar
  81. Tazi, A., Bouchonnet, F., Grandsaigne. M., Boumsell, L., Hance, A.J., and Soler, P., 1993, Evidence that granulocyte-macrophage-colony stimulating factor regulates the distribution and differentiated state of dendritic cells/Langerhans cells in human lung and lung cancers, J. Clin. Invest. 91:566–576.PubMedCrossRefGoogle Scholar
  82. Takahashi, H., Nakagaway, Y., Yokomuro, K., and Berzofsky, J.A., 1993, Induction of CD8+ cytotoxic T lymphocytes by immunization with syngeneic irradiated HIV-1 envelope derived peptide-pulsed dendritic cells, Int. Immunol. 5:849–857.PubMedCrossRefGoogle Scholar
  83. Tarte, K., Lu, Z.Y., Fiol, G., Legouffe. E., Rossi, J.F., and Klein, B., 1997, Generation of virtually pure and potentially proliferating dendritic cells from non-CD34 apheresis cells from patients with multiple myeloma, Blood 90:3482–3495.PubMedGoogle Scholar
  84. Thomas, R., Davis, L., and Lipsky, P., 1993, Isolation and characterization of human peripheral blood dendritic cells, J. Immunol. 150:821–834.PubMedGoogle Scholar
  85. Thompson, J.A., Gruner, T.F., and Zimmermann, W., 1991, Carcinoembryonic antigen gene family: molecular biology and clinical prospectives, J. Clin. Lab. Anal. 5:344–366.PubMedCrossRefGoogle Scholar
  86. Tsang, K.Y, Zaremba, S., Nieroda, C.A., Zhu, M.Z., Hamilton, J.M., and Schlom, J., 1995, Generation of human cytotoxic T cells specific for human carcinoembryonic antigen epitopes from patients immunized with recombinant vaccinia-CEA vaccine, J. Natl. Cancer Inst. 87:982–990.PubMedCrossRefGoogle Scholar
  87. Valone, F.H., Small, E.J., Whisenant, S., Peshwa, M., Strang, G., Laus, R., Ruegg, C., and van Schooten, W., 1998. Immunotherapy of hormone refractory prostate cancer with antigen-pulsed dedritic cells: A Phase I/II study, Proc. Am. Soc. Clin. Oncol. 17:346a.Google Scholar
  88. Van den Eynde, B., Hainut, P., Herin, M., Knuth, A., Lemoine, C., Weynants, P., van der Bruggen. P.C., Fauchet, R., and Boon, T., 1989, Presence on a human melanoma of multiple antigens recognized by autologous CTL, Int. J. Cancer 44:634–640.PubMedCrossRefGoogle Scholar
  89. Van der Bruggen, P.C., Traversari, C., Chomez, P., Lurquin, C., De Plaen, E., Van den Eynde, B., Knuth, A., and Boon, T., 1991, A gene encoding an antigen recognized by cytotoxic T lymphocytes on a human melanoma, Science 254:1643–1647.PubMedCrossRefGoogle Scholar
  90. Van Pel, A., and Boon. T, 1982, Protection against a nonimmunogenic mouse leukemia by an immunogenic variant obtained by mutagenesis, Proc. Natl. Acad. Sci. USA 79:4718–4722.PubMedCrossRefGoogle Scholar
  91. Van Voorhis, W.C., Hair, L.S., Steinman, R.M., and Kaplan, G., 1982, Human dendritic cells: Enrichment and characterization from peripheral blood, J. Exp. Med 155:1172–1187.PubMedCrossRefGoogle Scholar
  92. Vremee, D., Zorbas, M., Scollay, R., Saunders, D., Ardavin, C., Wu, L., and Shortman, K., 1992, The surface phenotype of dendritic cells purified from mouse thymus and spleen: investigation of the CD8 expression by a subpopulation of dendritic cells, J. Exp. Med 176:47–58.CrossRefGoogle Scholar
  93. Williams, L.A., Egner, W., and Hart, D.N.J., 1994, Isolation and function of human dendritic cells, Int. Rev. Cytol. 153:41–103.PubMedCrossRefGoogle Scholar
  94. Wong, C., Morse, M.A., and Nair, S.K., 1998, Induction of primary, human antigen-specific cytotoxic T lymphocytes in vitro using dendritic cells pulsed with peptides, J. Immunother. 21:32–40.PubMedCrossRefGoogle Scholar
  95. Young, J.W., and Steinman, R.M., 1990, Dendritic cells stimulate primary human cytolytic lymphocyte responses in the absence of CD4+ helper T cells, J. Exp. Med. 171:1315–1332.PubMedCrossRefGoogle Scholar
  96. Young, J.W., and Steinman, R.M., 1988, Accessory cell requirements for the mixed-leukocyte reaction and polyclonal mitogens, as studied with a new technique for enriching blood dendritic cells, Cell. Immunol. 111:167–182.PubMedCrossRefGoogle Scholar
  97. Zhou, L.-J., and Tedder, T.F., 1995, Human blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamily, J. Immunol. 154:3821–3835.PubMedGoogle Scholar
  98. Zhou, L.-J., and Tedder, T.F., 1996, CD14+ Blood monocytes can differentiate into functionally mature CD83+ dendritic cells, Proc. Natl. Acad Sci. USA 93:2588–2592.PubMedCrossRefGoogle Scholar
  99. Zitvogel, L., Mayordomo, J.I., Tjandrawan, T., DeLeo, A.B., Clarke, M.R., Lotze, M.T., and Storkus, W.J., 1996, Therapy of murine tumors with tumor peptide pulsed dendritic cells: dependence on T cells, B7 costimulation, and Thl-asssociated cytokines, J. Exp. Med. 183:87–97.PubMedCrossRefGoogle Scholar
  100. Zitvogel, L., Regnault, A., Lozier, A., Wolfers, J., Flament, C., Tenza, D. Ricciardi-Castagnoli, P., Raposo, G., and Amigorena, S., 1998, Eradication of established murine tumors using a novel cell-free vaccine; dendritic cell-derived exosomes, Nature Med. 4:594–600.PubMedCrossRefGoogle Scholar

Copyright information

© Kluwer Academic Publishers 2002

Authors and Affiliations

  • Michael A. Morse
    • 1
  • H. Kim Lyerly
    • 2
  1. 1.Department of MedicineDuke University Medical CenterDurham
  2. 2.Department of SurgeryDuke University Medical CenterDurham

Personalised recommendations